Evidence map›Paper›PMID 38305364›Full record

ArticleThe Biochemical journal2024

Role of the leucine-rich repeat protein kinase 2 C-terminal tail in domain cross-talk.

Pallavi Kaila Sharma, Jui-Hung Weng, Jascha T Manschwetus, Jian Wu, Wen Ma, Friedrich W Herberg, Susan S Taylor

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Pallavi Kaila SharmaDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0652, U.S.A.
Jui-Hung WengDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0652, U.S.A.
Jascha T ManschwetusDepartment of Biochemistry, University of Kassel, Heinrich-Plett-Str. 40, 34132 Kassel, Hessen, Germany.ORCID 0000-0003-3136-9153
Jian WuDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0652, U.S.A.
Wen MaDepartment of Physics, University of Vermont, Burlington, Vermont.
Friedrich W HerbergDepartment of Biochemistry, University of Kassel, Heinrich-Plett-Str. 40, 34132 Kassel, Hessen, Germany.ORCID 0000-0001-7117-7653
Susan S TaylorDepartment of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0652, U.S.A.ORCID 0000-0002-7702-6108
University of California San Diego · USUniversity of Kassel · DEUniversity of Vermont · US

Funding

THEORY OF BIOMOLECULAR DIFFUSIONR01GM031749 · NIGMS · UNIVERSITY OF HOUSTON · PI HUBER, GARY ALEXANDER, MCCAMMON, JAMES ANDREW · 1985 to 2022
$7.8M
Lessons Learned from PKA: Assembly of Dynamic Macromolecular SwitchesR35GM130389 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN S. TAYLOR · 2019 to 2026
$5.7M
Synapt G2-S System with HXMS AutomationS10OD016234 · OD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KOMIVES, ELIZABETH A. · 2013 to 2013
$600k
NIGMS NIH HHS R01 GM031749NIGMS NIH HHS R35 GM130389NIH HHS S10 OD016234
6 · The paper itself

Abstract

Leucine-rich repeat protein kinase 2 (LRRK2) is a multi-domain protein encompassing two of biology's most critical molecular switches, a kinase and a GTPase, and mutations in LRRK2 are key players in the pathogenesis of Parkinson's disease (PD). The availability of multiple structures (full-length and truncated) has opened doors to explore intra-domain cross-talk in LRRK2. A helix extending from the WD40 domain and stably docking onto the kinase domain is common in all available structures. This C-terminal (Ct) helix is a hub of phosphorylation and organelle-localization motifs and thus serves as a multi-functional protein : protein interaction module. To examine its intra-domain interactions, we have recombinantly expressed a stable Ct motif (residues 2480-2527) and used peptide arrays to identify specific binding sites. We have identified a potential interaction site between the Ct helix and a loop in the CORB domain (CORB loop) using a combination of Gaussian accelerated molecular dynamics simulations and peptide arrays. This Ct-Motif contains two auto-phosphorylation sites (T2483 and T2524), and T2524 is a 14-3-3 binding site. The Ct helix, CORB loop, and the CORB-kinase linker together form a part of a dynamic 'CAP' that regulates the N-lobe of the kinase domain. We hypothesize that in inactive, full-length LRRK2, the Ct-helix will also mediate interactions with the N-terminal armadillo, ankyrin, and LRR domains (NTDs) and that binding of Rab substrates, PD mutations, or kinase inhibitors will unleash the NTDs.

Indexed as

Leucine-Rich Repeat ProteinsProtein Serine-Threonine KinasesLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MutationPeptidesPhosphorylationProtein DomainsLeucine-Rich Repeat ProteinsLeucine-Rich Repeat Serine-Threonine Protein Kinase-2PeptidesProtein Serine-Threonine KinasesC-terminal helixGaMD simulationLRRK2Parkinson's diseasepeptide array

Identifiers

PMID38305364
PMCPMC10903466
OpenAlexW4391474271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.